ENTITY

Cryofocus Medtech (Shanghai) (6922 HK)

4
Analysis
Health Care • China
Cryofocus Medtech (Shanghai) specializes in the research, development, manufacturing, and sale of minimally invasive interventional medical devices, primarily utilizing cryoablation technology. The company's product portfolio addresses vascular interventional therapy for cardiovascular diseases such as atrial fibrillation and hypertension, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases including bladder cancer and gastric cancer. Headquartered in Shanghai, China, the company was founded in 2013.
more
Exchange Announcement • 24 Sep 2026 16:56

Interim Report 2026

Exchange Announcement • 28 Aug 2026 18:00

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 18 Aug 2026 16:38

Date Of Board Meeting

Exchange Announcement • 05 Jun 2026 17:54

Poll Results Of The 2025 Annual General Meeting Held On June 5, 2026

No more filings
x